Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.51 | N/A |
| PEG Ratio (TTM) | -0.20 | N/A |
| P/S Ratio (TTM) | 0.34 | N/A |
| P/B Ratio (TTM) | 3.00 | N/A |
| P/FCF Ratio (TTM) | -25.77 | N/A |
| Price to 5YR AVG Earnings Ratio | 26.00 | N/A |
| Price to 5YR AVG FCF Ratio | 42.39 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.94% | N/A |
| ROE (TTM) | 29.50% | N/A |
| Net Profit Margin (TTM) | 3.25% | N/A |
| ROIC 5YR AVG | 8.01% | N/A |
Growth (48%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -52.49% | -12.81% | 38.89% |
| Revenue | 0.31% | -0.96% | 10.58% |
| Net Income | -7.46% | -13.23% | 39.60% |
| Cash Flow | 209.22% | 482.57% | 298.43% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.63 | N/A |
| Quick Ratio (TTM) | 0.57 | N/A |
| D/E Ratio (TTM) | 1.48 | N/A |
| Interest Coverage (TTM) | 6.83 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 2.37 | N/A |
| LTL to 5YR AVG FCF | 43.23 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.13% | N/A |